Opus Genetics Announces Pricing of Public Offering and Concurrent Private Placement with Proceeds of Over $20 Million
The public offering was led by Perceptive Advisors and Nantahala Capital, with participation from other new institutional biotech investors. Company CEO George Magrath and board chairman Cam Gallagher ...
Alumis Reports Year End 2024 Financial Results and Highlights Recent Achievements
Presented Phase 2 STRIDE OLE 52-week psoriasis data at AAD 2025 demonstrating next-generation oral TYK2 inhibitor ESK-001 treatment led to ...
Microchip Technology Announces Pricing Of Offering Of Depositary Shares Representing Interests In Series A Mandatory Convertible Preferred Stock
This announcement is neither an offer to sell nor a solicitation of an offer to buy any of these securities and shall not constitute an offer, solicitation or sale in any jurisdiction in which such ...
Electrolyte Drink Mix Sues Supplement Brand Over Similar Trademarks
This action was surfaced by Law.com Radar, which delivers real-time alerting on new litigation across more than 2,600 state ...